Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BeyondSpring Inc. (BYSI)

  • Technical Exchange News
  • Feb. 20, 2024, 18:48 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Normal.

Comment Full text

Avalo Therapeutics Inc. (AVTX)

  • Technical Exchange News
  • Feb. 20, 2024, 18:48 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Feb. 20, 2024, 18:48 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eargo Inc (EAR)

  • Technical Exchange News
  • Feb. 20, 2024, 00:26 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Eargo, Inc. - Common Stock. New value: Eargo, Inc. - Common Stock.

Comment Full text

Eargo Inc (EAR)

  • Technical Exchange News
  • Feb. 20, 2024, 00:26 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Eargo, Inc. - Common Stock.

Comment Full text

Eargo Inc (EAR)

  • Technical Exchange News
  • Feb. 20, 2024, 00:26 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Eargo, Inc. - Common Stock.

Comment Full text

Vaxxinity Inc. (VAXX)

  • Technical Exchange News
  • Feb. 16, 2024, 19:03 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Alaunos Therapeutics Inc (TCRT)

  • Technical Exchange News
  • Feb. 16, 2024, 19:03 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Novo Integrated Sciences Inc (NVOS)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Technical Exchange News
  • Feb. 16, 2024, 19:02 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 788
  • 789
  • 790
  • 791
  • 792
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250715)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150046)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin